Ligand · 0OF
0OF · (3S)-1-ethyl-3-[3-hydroxy-5-(pyridin-3-yl)phenyl]-5-phenyl-7-(trifluoromethyl)-1H-1,5-benzodiazepine-2,4(3H,5H)-dione
0OF, (3S)-1-ethyl-3-[3-hydroxy-5-(pyridin-3-yl)phenyl]-5-phenyl-7-(trifluoromethyl)-1H-1,5-benzodiazepine-2,4(3H,5H)-dione (C29 H22 F3 N3 O3, 517.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- 0OF
- Formula
- C29 H22 F3 N3 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0OF in 2 structures; the first of them:
- 4E91 · Crystal Structure of the N-Terminal Domain of HIV-1 Capsid in Complex With Inhibitor BD3 · 0OF A202 · binds TRP23, VAL27, GLU28, LYS30, ALA31, PHE32, SER33, VAL36 and 14 more
- 4E91 · Crystal structure of the N-terminal domain of HIV-1 capsid in complex with inhibitor BD3 · 0OF A202 · binds TRP23, VAL27, GLU28, LYS30, ALA31, PHE32, SER33, VAL36 and 14 more
Residues it binds most
VAL 2, LEU 2, ALA 2, GLY 2, ILE 2, MET 2, PHE 2, GLU 2, HIS 2, LYS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.